New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro
P-glycoprotein (Pgp) determines resistance to a broad spectrum of drugs used against glioblastoma multiforme (GB). Indeed, Pgp is highly expressed in GB stem cells and in the brain-blood barrier (BBB), the peculiar endothelium surrounding the brain. Inhibiting Pgp activity in the BBB and GB is still...
Main Authors: | Iris Chiara Salaroglio, Elena Gazzano, Joanna Kopecka, Konstantin Chegaev, Costanzo Costamagna, Roberta Fruttero, Stefano Guglielmo, Chiara Riganti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/23/6/1401 |
Similar Items
-
Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update
by: Jen-Fu Hsu, et al.
Published: (2021-01-01) -
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer
by: Iris C. Salaroglio, et al.
Published: (2018-11-01) -
A Case With Multicentric Glioblastoma Multiforme
by: Elif Tolgay, et al.
Published: (2008-08-01) -
Prognostic factors in glioblastoma multiforme
by: Leonardo Welling, et al.
Published: (2010-12-01) -
Cerebellar giant cell glioblastoma multiforme in an adult
by: Sudhansu Sekhar Mishra, et al.
Published: (2014-07-01)